BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2184878)

  • 1. Intravesical therapy in the management of superficial transitional cell carcinoma of the bladder: the experience of the EORTC GU Group.
    Newling D
    Br J Cancer; 1990 Apr; 61(4):497-9. PubMed ID: 2184878
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravesical adjuvant treatment in superficial bladder cancer. A review of the question after 15 years of experience with the EORTC GU group.
    Bouffioux C
    Scand J Urol Nephrol Suppl; 1991; 138():167-77. PubMed ID: 1838428
    [No Abstract]   [Full Text] [Related]  

  • 3. [Conservative treatment of superficial transitional cell carcinoma of the bladder].
    Gruenwald I; Stein A; Lurie A
    Harefuah; 1995 Jan; 128(2):104-11. PubMed ID: 7721171
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravesical therapy: does it affect the natural history of superficial bladder cancer?
    Lamm DL; Griffith JG
    Semin Urol; 1992 Feb; 10(1):39-44. PubMed ID: 1565903
    [No Abstract]   [Full Text] [Related]  

  • 5. Superficial transitional (Ta/T1/CIS) cell carcinoma of the bladder.
    Konety BR; Williams RD
    BJU Int; 2004 Jul; 94(1):18-21. PubMed ID: 15217424
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravesical therapy for bladder cancer.
    Kamat AM; Lamm DL
    Urology; 2000 Feb; 55(2):161-8. PubMed ID: 10688071
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravesical interferon alfa in the treatment of superficial bladder cancer.
    Williams RD
    Semin Oncol; 1988 Oct; 15(5 Suppl 5):10-3. PubMed ID: 3057641
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of superficial transitional cell carcinoma of the bladder.
    Fleischmann J; Goldberg G
    Semin Urol; 1993 Nov; 11(4):193-204. PubMed ID: 8290825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCG-(RIVM) versus mitomycin intravesical therapy in patients with superficial bladder cancer. EORTC GU Group and the Dutch South-East Collaborative Group.
    Debruyne FM; van der Meijden AP; Franssen MP
    Prog Clin Biol Res; 1989; 303():435-46. PubMed ID: 2506556
    [No Abstract]   [Full Text] [Related]  

  • 10. Contemporary management of superficial bladder cancer.
    Pow-Sang JM; Seigne JD
    Cancer Control; 2000; 7(4):335-9. PubMed ID: 10895127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravesical therapy for superficial bladder cancer.
    Malkowicz SB
    Semin Urol Oncol; 2000 Nov; 18(4):280-8. PubMed ID: 11101091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgery and intravesical chemotherapy in the management of superficial bladder cancer.
    Soloway MS
    Semin Urol; 1983 Feb; 1(1):23-33. PubMed ID: 6433424
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment modalities in superficial bladder cancer.
    Irwin R; Zincke H; Droller MJ; Prout GR; Soloway MS
    Semin Urol; 1989 Feb; 7(1 Suppl 1):1-12. PubMed ID: 2499916
    [No Abstract]   [Full Text] [Related]  

  • 14. High-risk superficial bladder cancer: intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladder.
    Pham HT; Soloway MS
    Semin Urol Oncol; 1997 Aug; 15(3):147-53. PubMed ID: 9394909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment and follow-up of superficial bladder cancer].
    Raitanen M
    Duodecim; 2002; 118(9):903-9. PubMed ID: 12238168
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pitfalls in intravesical immunotherapy of superficial carcinoma of the gallbladder with BCG vaccine].
    Pacík D; Vít V; Turjanica M
    Rozhl Chir; 1997 Jan; 76(1):3-5. PubMed ID: 9182342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of intravesical bacillus Calmette-Guérin in the treatment of superficial transitional cell carcinoma of the bladder: an overview.
    Witjes JA; vd Meijden AP; Debruyne FM
    Urol Int; 1990; 45(3):129-36. PubMed ID: 2190404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When does superficial bladder cancer resist intravesical therapy?
    Vögeli T; Ackermann R
    Semin Urol; 1990 Nov; 8(4):248-53. PubMed ID: 2284531
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravesical therapy for superficial bladder cancer: slow but steady progress.
    Lamm DL
    J Clin Oncol; 2003 Dec; 21(23):4259-60. PubMed ID: 14581444
    [No Abstract]   [Full Text] [Related]  

  • 20. Principles of intravesical chemotherapy and immunotherapy.
    Sarosdy MF
    Urol Clin North Am; 1992 Aug; 19(3):509-19. PubMed ID: 1636235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.